Abstract
Schizophrenia is believed to involve altered dopaminergic transmission. This is supported by the fact that chronic use of dopamine agonists such as amphetamine can cause psychotic symptoms, and dopamine D2 receptor antagonists are the most widely used drugs for the treatment of schizophrenia. However, most of the in vivo imaging studies with drug-free or drug-naive patients could not detect a significant change in striatal D2 receptors 1. On the other hand, neuropathological 2 and neuroimaging studies have demonstrated abnormalities in the extrastriatal regions of schizophrenia. Dopamine receptors are classified into five subtypes, and selective ligands have been developed for D1 and D2 subtypes. In the cortical regions, the density of D1 receptor is higher than that of D2 receptor3, 4 . Dl receptor has been implicated in the control of working memory. We have recently reported the abnormality of dopamine D1 receptor binding in the prefrontal cortex of patients with schizophrenia, and its relation to negative symptoms and poor performance in the Wisconsin Card Sorting Test5. On the other hand, an increasing body of evidence favors a crucial role of extrastriatal regions in the pathophysiology of positive symptoms, and the extrastriatal D2 receptor is expected to be the common site of action of antipsychotics 6. We found that extrastriatal dopamine D2 receptor was the site of antipsychotic drug action 7. However, unexpectedly, reduced D2 receptor binding was observed in the anterior cingulate cortex of patients with schizophrenia, and a significant negative correlation was observed between D2 receptor binding and the positive symptom score on Brief Psychiatric Rating Scale (BPRS) 8.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Lamelle, Imaging dopamine transmission in schizophrenia. Q. J. Nucl. Med.42, 211–221 (1998).
F. M. Benes, J. McSparren, E. D. Bird, J. P. SanGiovanni, S. L. Vincent, Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psych. 48, 996–1001(1991)
T. Suhara, H. Fukuda, O. Inoue, T. Itoh, K. Suzuki, T. Yamasaki, Y. Tateno, Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology, 103, 41–45 (1991).
T. Suhara, Y Sudo, T. Okauchi, J. Maeda, K. Kawabe, K. Suzuki, Y Okubo, Y Nakashima, H. Ito, S. Tanada, C. Halldin, L. Farde, Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int. J. Neuropsychopharmacol. 2, 73–82 (1999).
Y Okubo, T. Suhara, K. Suzuki, K. Kobayashi, O. Inoue, O. Terasaki, Y Someya, T. Sassa, Y Sudo, E. Matsushima, M. Iyo, Y Tateno, M. Toru. Decreased prefrontal dopamine Dl receptors in schizophrenia revealed by PET. Nature 385, 634–636 (1997).
L. Farde, T. Suhara, S. Nyberg, P. Karlsson, Y Nakashima, Y Hietala, C. A. Halldin, A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology 133, 396–404 (1997).
F. Yasuno, T. Suhara, Y Okubo, Y Sudo, M. Inoue, T. Ichimiya, S. Tanada, Dose relation of limbic-cortical D2-dopamine receptor occupancy with risperidone. Psychopharmacology 154, 112–114 (2001)
T Suhara, Y Okubo, F. Yasuno, Y Sudo, M. Inoue, T. Ichimiya, Y Nakashima, K. Nakayama, S. Tanada, K. Suzuki, C. Halldin, L. Farde, Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch. Gen. Psych, in press
H. Ito, Y Sudo, T. Suhara, Y Okubo, C. Halldin, L. Farde, Error analysis for quantification of [11C]FLB 457 binding to extrastriatal dopamine D2 receptor in the human brain. Neurolmage 13, 531–539 (2001)
T. Okauchi, T. Suhara, J. Maeda, K. Kawabe, S. Obayashi, K. Suzuki, Effect of endogenous dopamine on extrastriatal [11C]FLB 457 binding measured by PET. Synapse 41, 87–95 (2001)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Suhara, T. et al. (2002). Dopamine Receptors in Schizophrenia. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_99
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3538-3_99
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3388-1
Online ISBN: 978-1-4757-3538-3
eBook Packages: Springer Book Archive